Table 5.
Biological activities of sulfur-containing steroids.
| No. | Antitumor & Related Activity, (Pa) * | Specific Activities, (Pa) * | Additional Predicted Activity, (Pa) * |
|---|---|---|---|
| 72 | Antineoplastic (0.842) | Erythropoiesis stimulant (0.722) Prostate disorders treatment (0.688) |
Anti-eczematic (0.773) Anti-seborrheic (0.733) Anti-psoriatic (0.658) |
| 73 | Antineoplastic (0.868) | Diuretic (0.991) Anti-hyperaldosteronism (0.963) Antihypertensive (0.940) Renal disease treatment (0.934) |
Cardiotonic (0.850) Anti-ischemic, cerebral (0.822) Antiarthritic (0.741) Antithrombotic (0.691) |
| 74 | Antineoplastic (0.824) | Anti-osteoporotic (0.917) | Anti-seborrheic (0.845) |
| 75 | Antineoplastic (0.723) | Prostate disorders treatment (0.735) | Anti-eczematic (0.787) |
| 76 | Antineoplastic (0.736) | Prostate disorders treatment (0.745) | Anti-eczematic (0.813) |
| 77 | Antineoplastic (0.774) | Anesthetic general (0.774) | Anti-eczematic (0.809) |
| 78 | Antineoplastic (0.774) | Anesthetic general (0.774) Respiratory analeptic (0.675) |
Anti-eczematic (0.809) Anti-psoriatic (0.686) |
| 79 | Antineoplastic (0.773) Antimetastatic (0.682) |
Anti-osteoporotic (0.683) | Anti-eczematic (0.776) Anti-psoriatic (0.643) |
| 80 | Antineoplastic (0.729) Apoptosis agonist (0.680) |
Anti-osteoporotic (0.789) | Anti-eczematic (0.782) |
| 81 | Antineoplastic (0.681) | Anti-osteoporotic (0.730) | Anti-eczematic (0.798) |
| 82 | Antineoplastic (0.664) Apoptosis agonist (0.624) |
Anti-osteoporotic (0.742) | Anti-eczematic (0.771) Anti-psoriatic (0.619) |
| 83 | Antineoplastic (0.700) | Anti-osteoporotic (0.744) | Anti-eczematic (0.766) |
| 84 | Anesthetic general (0.761) | Anti-seborrheic (0.823) | |
| 85 | Antineoplastic (0.618) | Prostate disorders treatment (0.667) | Anti-seborrheic (0.817) |
| 86 | Prostate disorders treatment (0.652) | Anti-seborrheic (0.810) | |
| 87 | Antineoplastic (0.756) | Antiallergic (0.785) | Anti-psoriatic (0.818) Anti-eczematic (0.756) |
| 88 | Antineoplastic (0.658) | Prostate disorders treatment (0.669) | Dermatologic (0.692) Anti-eczematic (0.678) |
| 89 | Antineoplastic (0.730) | Anti-osteoporotic (0.696) |
* Only activities with Pa > 0.5 are shown.